Supplemental material
Open access
8,693
Views
54
CrossRef citations to date
0
Altmetric
Review
Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018
Karen M. MacDonaldDivision of Research, Matrix45, Tucson, AZ, USA
https://orcid.org/0000-0002-4568-9783View further author information
Abhishek KavatiHealth Economics & Outcomes Research, Novartis, East Hanover, NJ, USA
https://orcid.org/0000-0001-8890-1134View further author information
Benjamin OrtizClinical Development & Medical Affairs, Novartis, East Hanover, NJ, USA
https://orcid.org/0000-0001-6950-5582View further author information
Abdulaziz AlhossanCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia
https://orcid.org/0000-0001-5849-6756View further author information
Christopher S. LeeDivision of Research, Matrix45, Tucson, AZ, USA;Boston College, Connell School of Nursing, Boston, MA, USA
https://orcid.org/0000-0002-2510-4071View further author information
Ivo AbrahamDivision of Research, Matrix45, Tucson, AZ, USA;Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, Tucson, AZ, USA;Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA;Department of Family and Community Medicine, College of Medicine – Tucson, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
https://orcid.org/0000-0003-0490-4421View further author information
Pages 553-569
|
Received 02 Jan 2019, Accepted 23 Jan 2019, Published online: 14 Feb 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.